News Releases
Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
-
Jan 29, 2018- A total of 10 abstracts and one trial in progress (TIP) across various cancers to be presented during oral and poster sessions -
-
Jan 23, 2018
-
Dec 11, 2017- Gilteritinib combined with intensive chemotherapy was well-tolerated in newly diagnosed AML patients -
-
Nov 30, 2017- Accelerating the Discovery and Development of Novel Drugs that Target Mitochondrial Functions -